医护干预对老年血液病化疗后相关问题的影响

Influence of cure and nursing intervention to related problems after chemotherapy of hematonosis in elder patients

目的调查老年血液病化疗费用情况,寻找治疗效果好,成本低的治疗护理方案。方法将我院2004年12月27例接受化疗的老年血液病患者随机分组,实验组12例,采用化疗加免疫增强剂(胸腺肽α1)并实施保护性隔离措施;对照组15例,根据病情常规化疗,WBC<2.0×109/L时,实施保护性隔离。对2组患者的治疗护理相关费用、感染机率及护士的工作量进行对照研究。结果实验组与对照组在相关医疗费用、化疗后发热比率及化疗后3d总护理时数方面均有差异,(P<0.05)。结论对老年的血液病化疗患者,加用免疫增强剂(胸腺肽α1)和有效的预见性护理措施,可有效降低感染发生机率,减轻医疗费用负担,减轻临床护理工作量。

Objective To investigate the cost of old patients with hematonosis during chemothera py and to find the effective and low--cost treatments scheme. Methods 27 old hematonosis patients, accepting chemotherapy in December 2005, were divided into two groups randomly. 12 patients accepted chemotherapy plus immune intensifier （α1--Thymosin） and protective isolated measures. The other 15 patients accepted usual chemotherapy and were administered protective isolated measures when WBC 〈 2.0 × 10^9/Lo The costs, chance of infection and nursing workload of two groups were compared. Results Three above aspects of the two groups were significantly different （P 〈 0.05）. Conclusions immune intensifier （α1--Thymosin） and protective isolated measures can not only decrease the chance of infection and cost of treatment to elder hematonosis patients, but also relieve the nursing workload.